Loading stock data…
$2.81-0.07 (-2.41%)
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company in the Healthcare sector is trading at $2.81 with a market capitalization of $35M. The stock is currently near its 52-week low of $2.62, remaining 50.3% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 10 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.64M↓ | $8.61M↑ | $4.79M↓ | $10.56M↑ | $9.90M |
| Gross Profit | $3.96M↓ | $4.17M↑ | $2.18M↓ | $7.23M↑ | $6.62M |
| Operating Income | -$29.42M↑ | -$32.17M↑ | -$37.48M↑ | -$186.51M↓ | -$20.41M |
| Net Income | -$113.50M↓ | -$43.27M↓ | -$33.11M↑ | -$257.23M↓ | -$42.31M |
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescript...